Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,165 | 209 | 98.8% |
| Education | $48.84 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $736.73 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $558.36 | 15 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $380.96 | 23 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $359.99 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $310.94 | 15 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $283.82 | 5 | $0 (2024) |
| Alkermes, Inc. | $245.08 | 13 | $0 (2024) |
| ITI, Inc. | $196.10 | 11 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $191.70 | 10 | $0 (2023) |
| Corium, LLC | $169.50 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,786 | 66 | Janssen Pharmaceuticals, Inc ($339.79) |
| 2023 | $1,667 | 97 | ABBVIE INC. ($328.04) |
| 2022 | $508.21 | 33 | ABBVIE INC. ($156.63) |
| 2021 | $251.90 | 14 | AbbVie Inc. ($87.18) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 9 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/08/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/25/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: CNS | ||||||
| 03/15/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: PSYCHIATRY | ||||||
| 02/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2021 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 180 | 574 | $90,752 | $35,712 |
| 2022 | 7 | 221 | 576 | $85,250 | $35,145 |
| 2021 | 1 | 20 | 21 | $2,310 | $310.90 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 365 | $60,837 | $23,518 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 171 | $18,655 | $7,977 | 42.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $7,425 | $2,465 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 16 | $3,835 | $1,753 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 361 | $47,080 | $22,619 | 48.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 27 | 27 | $10,125 | $2,952 | 29.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 37 | 79 | $10,490 | $2,869 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 61 | $6,825 | $2,845 | 41.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 19 | 20 | $5,860 | $2,275 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 16 | $3,730 | $1,324 | 35.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 12 | 12 | $1,140 | $260.27 | 22.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 21 | $2,310 | $310.90 | 13.5% |
About Edward Evard, PMHNP
Edward Evard, PMHNP is a Psychiatric/Mental Health healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2020. The National Provider Identifier (NPI) number assigned to this provider is 1396344693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edward Evard, PMHNP has received a total of $4,214 in payments from pharmaceutical and medical device companies, with $1,786 received in 2024. These payments were reported across 210 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,165).
As a Medicare-enrolled provider, Evard has provided services to 421 Medicare beneficiaries, totaling 1,171 services with total Medicare billing of $71,168. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Virginia Beach, VA
- Active Since 10/19/2020
- Last Updated 10/19/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1396344693
Products in Payments
- VRAYLAR (Drug) $736.73
- SPRAVATO (Drug) $558.36
- INGREZZA (Drug) $359.99
- CAPLYTA (Drug) $311.06
- TRINTELLIX (Drug) $310.94
- Qelbree (Drug) $283.82
- ABILIFY MAINTENA (Drug) $220.37
- REXULTI (Drug) $215.04
- ARISTADA (Drug) $211.39
- HETLIOZ (Drug) $191.70
- Azstarys (Drug) $169.50
- Dyanavel XR (Drug) $97.59
- Auvelity (Drug) $93.53
- Sunosi (Drug) $73.46
- AUSTEDO (Drug) $66.76
- GRALISE (Drug) $61.42
- LATUDA (Drug) $50.05
- NUEDEXTA (Drug) $41.87
- Austedo XR (Drug) $36.65
- VIVITROL (Drug) $33.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Virginia Beach
Genise Binns
Psychiatric/Mental Health — Payments: $10,066
Mrs. Nakeshia Mouzon, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $6,575
Mary Crutchfield, Pmhnp, Fnp, PMHNP, FNP
Psychiatric/Mental Health — Payments: $6,091
Mrs. Arnella Edwards
Psychiatric/Mental Health — Payments: $5,663
Jamie Deputy, Msn, Aprn, Pmhnp-Bc, MSN, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,582
Brittany Smith, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,301